Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

NEWS ABOUT >

Biotechnology

Clean Rooms

Clinical Trials

Consultants

Digitalization

Drug Discovery & Development

Engineering

Global Pharma

Industrial talks

Ingredients

Lab Equipment

Logistics & Distribution

Manufacturing

Market

Outsourcing

Packaging

Quality / GMP

Regulation

Safety

Last edition

All magazines
Subscribe to our magazine

News about "ENHANCE-3"

Merck Initiates Phase 3 ENHANCE-3 Trial of Ohtuvayre for COPD Exacerbation Prevention

Merck initiates the phase 3 ENHANCE-3 clinical trial to evaluate Ohtuvayre for preventing COPD exacerbations in adults receiving standard-of-care treatment.

ENHANCE-3 | 05/11/2026 | By News Bureau

Merck Initiates Phase 3 ENHANCE-3 Trial of Ohtuvayre for COPD Exacerbation Prevention

Merck initiates the phase 3 ENHANCE-3 clinical trial to evaluate Ohtuvayre for preventing COPD exacerbations in adults receiving standard-of-care treatment.

ENHANCE-3 | 05/11/2026 | By News Bureau

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members